We've come a long way from 2020 and 2021 when digital economy stocks were soaring to impossible heights. Some of these stocks have ceased to exist. Others have fallen hard as the economy has reopened ...

One of the best ways to grab a dividend payer set to surge is a strategy you never hear about anymore: Pick up shares of a conglomerate. The deal on these companies is that they’re basically a ...

CRISPR Therapeutics' first approved therapy, Casgevy, was a breakthrough. One of Casgevy's biggest achievements may be demonstrating the viability of CRISPR Therapeutics' strategy. The biotech company ...

C3.ai (AI) stock has dropped 59% over the past year to a $2B market cap. The company is down 92% from its peak. C3.ai revenue fell 20% year-over-year to $75.1M. The company burned through $86M in cash ...

MarketAxess reported strong Q3’24 results with revenue of $207 million, driven by increased market volumes and impressive operating leverage, leading to a 30% EPS growth. The company's global strategy ...

In today's video, I will be talking about the recent updates regarding Enphase (NASDAQ: ENPH). Check out the short video to learn more, consider subscribing, and click the special offer link below.

Wix.com has quietly been making an impressive comeback. Though it rallied in 2023, Wix's story as a profitable growth business is still fresh. The stock could be very reasonably priced for 2024. It's ...